Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AS-3201 (ranirestat) in diabetic sensorimotor polyneuropathy
jRCT2080221949Phase 2
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic peripheral polyneuropathy (DPN) and diabetic polyneuropathy (DPN) comparing Ranirestat 20 mg with Placebo (2 arms).
02
Drugs
ranirestat
03
Conditions
diabetic peripheral polyneuropathy (DPN)diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on jRCT2080221949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221949.